Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Zero Minis - Acceptability and Tolerance Market Research

NCT06298292 is registered in ClinicalTrials.gov with metaX Institut fuer Diatetik GmbH as lead sponsor.

NCT NCT06298292
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06298292 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Zero Minis - Acceptability and Tolerance Market Research
Lead sponsor
metaX Institut fuer Diatetik GmbH
Phase
Observational
Overall status
Unknown status
Start date
April 1, 2024
Completion date
June 30, 2026
Enrollment
15 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

alkaptonuria, homocystine; metabolic disorder, msud (maple syrup urine disease), tyrosinemia, type i, tyrosinemia, type ii, tyrosinemia, type iii